Faron Pharmaceuticals Ltd: Registration of New Shares

Summary by AI BETAClose X

Faron Pharmaceuticals Ltd. has approved the exercise of 517,795 Special Rights, resulting in the issuance of 517,795 new shares for an aggregate subscription price of EUR 965,998.35. Following this issuance and registration, the total number of ordinary shares in the company is now 118,563,143, with 4,142,678 shares held in treasury, leading to a total of 114,420,465 voting rights. Trading of these new shares is anticipated to commence on First North and AIM around December 5, 2025.

Disclaimer*

UK 100

Latest directors dealings